Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit Nov 29, 2023 04:05PM
Terns Pharmaceuticals to Participate in the JMP Securities 2023 Life Sciences Conference May 9, 2023 04:05PM
Terns Announces Closing of Public Offering of Shares of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Dec 23, 2022 04:05PM
Terns Announces Closing of Public Offering of Shares of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Dec 23, 2022 04:05PM
Terns Pharmaceuticals (TERN) Prices 10.35M Share Offering at $7.25/sh Dec 21, 2022 05:57AM


Dec 20, 2022 07:39PM Terns Announces Pricing of $75 Million Public Offering
Dec 20, 2022 07:39PM Terns Announces Pricing of $75 Million Public Offering
Dec 19, 2022 04:31PM Terns Pharmaceuticals Inc. (TERN) Launches $75M Public Offering
Dec 19, 2022 04:31PM Terns Announces Proposed Public Offering
Dec 19, 2022 04:31PM Terns Announces Proposed Public Offering
Dec 1, 2022 04:05PM Terns Pharmaceuticals to Present at the 2022 JMP Securities Hematology and Oncology Summit